Towards novel treatments for schizophrenia: molecular and behavioural signatures of putative antipsychotic drug SEP-363856EUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72020-11-010PREAI
Long-term effects of stress early in life on microRNA-30a and its network: Preventive effects of lurasidone and potential implications for depression vulnerabilityNEUROBIOLOGY OF STRESSIF3.62020-11-0124OAAI
Differential effects of MGluR5 receptor blockade on behavior, schizophrenia-relevant gene expression and neuronal activation patterns from development to aging miceEUROPEAN PSYCHIATRYIF6.72020-03-231PREAI
Fetal glucocorticoid receptor (Nr3c1) deficiency alters the landscape of DNA methylation of murine placenta in a sex-dependent manner and is associated to anxiety-like behavior in adulthoodTRANSLATIONAL PSYCHIATRYIF6.22019-01-1722OAAI
Placental miR-340 mediates vulnerability to activity based anorexia in miceNATURE COMMUNICATIONSIF15.72018-04-2320OAAI
DIFFERENTIAL EFFECTS OF MGLU5 RECEPTOR BLOCKADE ON BEHAVIOR, SCHIZOPHRENIA-RELEVANT GENE EXPRESSION AND NEURONAL ACTIVATION PATTERNS FROM DEVELOPMENT TO AGING MICESCHIZOPHRENIA BULLETINIF4.82018-04-010OAAI
FoxO1, A2M, and TGF-β1: three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analysesMOLECULAR PSYCHIATRYIF10.12018-01-0471OAAI
Molecular and cellular dissection of NMDA receptor subtypes as antidepressant targetsNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92018-01-0124PREAI
Identification of a long lasting stress signature associated with enhanced vulnerability for depression by using omics' and cross species approachesEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72017-10-010PREAI
FOXO1, A2M and TGFB1: Three Novel Genes Predicting Depression in Gene X Environment Interactions Are Identified Using Cross-Species and Cross-Tissues Transcriptomic and Mirnomic AnalysesBIOLOGICAL PSYCHIATRYIF92017-05-010OAAI
Chronic lurasidone treatment normalizes GABAergic marker alterations in the dorsal hippocampus of mice exposed to prenatal immune activationEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72017-02-0124OAAI
Ankyrin-3 as a molecular marker of early-life stress and vulnerability to psychiatric disordersTRANSLATIONAL PSYCHIATRYIF6.22016-11-0831OAAI
MicroRNAs and psychiatric disorders: From aetiology to treatmentPHARMACOLOGY & THERAPEUTICSIF12.52016-11-0149PREAI
Modulation of SGK1 system induced by stress early in lifeBRAIN BEHAVIOR AND IMMUNITYIF7.62016-10-010PREAI
Long-term signature after stress early in life by using mRNA-microRNA integration approach in rats and humansEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72016-10-010PREAI
Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptorsEUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCEIF3.72016-08-316PREAI
Stress signature in prenatally stressed rats and in the blood of subjects with childhood trauma history: mRNA-MicroRNA integration approachEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72015-09-011PREAI
Early-life trauma as susceptibility to develop depression in hepatitis C virus patients following long-term treatment with interferon-alphaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72015-09-010PREAI
Inflammatory related pathways and SGK1 signaling as targets of early life stressful events: role of DNA methylation and microRNAsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72015-09-010PREAI
Prenatal Stress as a Risk Factor for Major Depression: an Investigation On Therapeutic Intervention with Antipsychotics and the Role of Social Stimuli During PeriadolescenceEUROPEAN PSYCHIATRYIF6.72015-03-011PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向